Exelixis, Inc. (EXEL)

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

California Public Employees Retirement System decreased its position in Exelixis, Inc. (NASDAQ: EXEL) by 59.2% during the undefined quarter, according to its most recent filing with the SEC. The insti...

Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D Day Transcript...

Cresset Asset Management LLC cut its position in shares of Exelixis, Inc. (NASDAQ: EXEL) by 44.0% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange...

Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock?...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that it will webcast its virtual event, Exelixis 2025 R&D Day: Building Next-generation Oncology Franchises, on Wednesda...

Arrowstreet Capital Limited Partnership lifted its position in shares of Exelixis, Inc. (NASDAQ: EXEL) by 42.9% during the second quarter, according to the company in its most recent filing with the S...

Axsome Therapeutics boasts a deep late-stage pipeline with billions in potential revenue opportunity. Exelixis' core franchise remains strong while it develops promising new medicines....

Capital Fund Management S.A. increased its holdings in shares of Exelixis, Inc. (NASDAQ: EXEL) by 6.6% in the second quarter, according to the company in its most recent Form 13F filing with the Secur...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....